Skip to main content
NCBI home page
Medline Book to support NIHPA logoLink to Medline Book to support NIHPA
. 2024 Nov 7;(213):CS353885. doi: 10.15620/cdc/64018

Symptoms of Anxiety and Depression Among Adults: United States, 2019 and 2022.

Emily P Terlizzi, Benjamin Zablotsky
PMCID: PMC11616099  PMID: 39591466

Abstract

OBJECTIVE

This report examines the prevalence of symptoms of anxiety and depression among adults by sociodemographic and geographic characteristics, and how those may have changed between 2019 and 2022.

METHODS

Data from the 2022 National Health Interview Survey were used to examine the prevalence of symptoms of anxiety, using the Generalized Anxiety Disorder scale (GAD-7), and symptoms of depression, using the Patient Health Questionnaire depression scale (PHQ-8).

RESULTS

During 2022, about one in five adults age 18 and older experienced any symptoms of anxiety (18.2%) or symptoms of depression (21.4%) in the past 2 weeks. The severity of symptoms differed by sociodemographic and geographic characteristics. The percentages of adults with mild, moderate, or severe symptoms of both anxiety and depression were highest among adults ages 18-29 and decreased with age and were higher among women than men. Asian non-Hispanic adults were least likely to experience moderate and severe symptoms of anxiety and depression compared with the other race and Hispanic-origin groups examined. In addition, the percentage of adults with any symptoms of anxiety and depression was highest among those with less than a high school education and with family incomes less than 100% of the federal poverty level and was higher among those living in rural areas. A significant increase was seen in the percentage of adults with anxiety symptoms (from 15.6% to 18.2%, respectively) and depression symptoms (from 18.5% to 21.4%, respectively) between 2019 and 2022. Increases in symptoms of anxiety and depression were seen throughout the subgroups examined, including adults ages 18-44, Black non-Hispanic and White non-Hispanic adults, adults with a high school education or more, and adults with family incomes of 100% of the federal poverty level or higher, as well as adults from all regions and urbanization levels.

Full text of this article can be found in Bookshelf.

References

  1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders (DSM-5). 5th ed. Arlington, VA. 2013.
  2. Terlizzi EP, Villarroel MA.. Symptoms of generalized anxiety disorder among adults: United States, 2019. NCHS Data Brief, no 378. Hyattsville, MD: National Center for Health Statistics. 2020. [PubMed]
  3. Villarroel MA, Terlizzi EP.. Symptoms of depression among adults: United States, 2019. NCHS Data Brief, no 379. Hyattsville, MD: National Center for Health Statistics. 2020. [PubMed]
  4. Barnes AL, Murphy ME, Fowler CA, Rempfer MV.. Health-related quality of life and overall life satisfaction in people with serious mental illness. Schizophrenia Res Treatment 2012:245103. 2012.PMC3507053 [DOI] [PubMed]
  5. Eisner MD, Blanc P.D., Yelin EH, Katz PP, Sanchez G, Iribarren C, Omachi TA.. Influence of anxiety on health outcomes in COPD. Thorax 65(3):229–34. 2010.PMC3111227 [DOI] [PubMed]
  6. Sher Y, Lolak S, Maldonado JR.. The impact of depression in heart disease. Curr Psychiatry Rep 12:255–64. 2010. doi: 10.1007/s11920-010-0116-8. [DOI] [PubMed]
  7. Gelenberg AJ. The prevalence and impact of depression. J Clin Psychiatry: 71(3). 2010. doi: 10.4088/JCP.8001tx17c. [DOI] [PubMed]
  8. Hysenbegasi A, Hass SL, and CR Rowland. The impact of depression on the academic productivity of university students. J Ment Health Policy Econ 8(3):145. 2005. [PubMed]
  9. Conti DJ, Burton WN.. The economic impact of depression in a workplace. J Occup Med., 36(9):983–88. 1994. [PubMed]
  10. Van Ameringen M., Mancini C, Farvolden P.. The impact of anxiety disorders on educational achievement. J Anxiety Disord 17(5): 561–71. 2003. doi: 10.1016/s0887-6185(02)00228-1. [DOI] [PubMed]
  11. Haslam C, Atkinson S, Brown SS, Haslam, RA. Anxiety and depression in the workplace: Effects on the individual and organisation (a focus group investigation). J Affect Disord 88(2):209–15. 2005. doi: 10.1016/j.jad.2005.07.009. [DOI] [PubMed]
  12. Greenberg PE, Sisitsky T, Kessler RC, Finkelstein SN, Berndt ER, Davidson JR, et al. . The economic burden of anxiety disorders in the 1990s. J Clin Psychiatry 60(7):427–435. 1999 doi: 10.4088/jcp.v60n0702. [DOI] [PubMed]
  13. Vahratian A, Blumberg SJ, Terlizzi EP, Schiller JS.. Symptoms of anxiety or depressive disorder and use of mental health care among adults during the COVID-19 pandemic–United States, August 2020–February 2021. Morb Mortal Wkly Rep MMWR 70:490–4. 2021.PMC8022876 [DOI] [PubMed]
  14. National Center for Health Statistics. National Health Interview Survey, 2022 survey description. 2023. Available from: https://ftp.cdc.gov/pub/Health_Statistics/NCHS/Dataset_Documentation/NHIS/2022/srvydesc-508.pdf .
  15. American Psychiatric Association. DSM-IV: Diagnostic and statistical manual of mental disorders. 4th ed. Arlington, VA. 1994.
  16. Kessler RC, Andrews G, Colpe LJ, Hiripi E, Mroczek DK, Normand SL, et al. . Short screening scales to monitor population prevalences and trends in nonspecific psychological distress. Psychol Med 32(6):959–76. 2002. doi: 10.1017/s0033291702006074. [DOI] [PubMed]
  17. Spitzer RL, Kroenke K, Williams JBW, Löwe B.. A brief measure for assessing generalized anxiety disorder: The GAD–7. Arch Intern Med 166(10):1092–7. 2006. doi: 10.1001/archinte.166.10.1092. [DOI] [PubMed]
  18. Kroenke K, Spitzer RL, Williams JBW.. The PHQ–9: Validity of a brief depression severity measure. J Gen Intern Med 16(9):606–13. 2001.PMC1495268 [DOI] [PubMed]
  19. Löwe B, Decker O, Müller S, Brähler E, Schellberg D, Herzog W, Herzberg PY.. Validation and standardization of the generalized anxiety disorder screener (GAD–7) in the general population. Med Care 46(3):266–74. 2008. doi: 10.1097/MLR.0b013e318160d093. [DOI] [PubMed]
  20. Kroenke K, Spitzer RL, Williams JBW, Monahan PO, Löwe B.. Anxiety disorders in primary care: Prevalence, impairment, comorbidity, and detection. Ann Intern Med 146(5):317–25. 2007. doi: 10.7326/0003-4819-146-5-200703060-00004. [DOI] [PubMed]
  21. U.S. Census Bureau. Poverty thresholds. Available from: https://www.census.gov/data/tables/time-series/demo/income-poverty/historical-poverty-thresholds.html.
  22. National Center for Health Statistics. Multiple imputation of family income in 2022 National Health Interview Survey: Methods. 2023. Available from: https://www.census.gov/data/tables/time-series/demo/income-poverty/historical-poverty-thresholds.html.
  23. U.S. Census Bureau. Geographic terms and definitions. Available from: https://www.census.gov/programs-surveys/popest/about/glossary/geo-terms.html.
  24. Ingram DD, Franco SJ.. NCHS urban–rural classification scheme for counties. Vital and health statistics. Vital Health Stat 2(154):1–65. 2012. [PubMed]
  25. StataCorp LP. Stata (Release 17 SE) [computer software]. 2021.
  26. Parker JD, Talih M, Malec DJ, Beresovsky V, Carroll M, Gonzalez JFJr, et al. . National Center for Health Statistics data presentation standards for proportions. National Center for Health Statistics. Vital Health Stat 2(175). 2017. [PubMed]
  27. Altemus M, Sarvaiya N, Epperson CN.. Sex differences in anxiety and depression clinical perspectives. Front Neuroendocrinol 35(3): 320–30. 2014.PMC4890708 [DOI] [PubMed]
  28. Ettman CK, Abdalla SM, Cohen GH, Sampson L, Vivier PM, Galea S.. Prevalence of depression symptoms in US adults before and during the COVID-19 pandemic. JAMA Netw Open 3(9):e2019686. 2020.PMC7489837 [DOI] [PubMed]
  29. Santabárbara J, Lasheras I, Lipnicki DM, Bueno-Notivol J, Pérez-Moreno M, López-Antón R, et al. . Prevalence of anxiety in the COVID-19 pandemic: An updated meta-analysis of community-based studies. Prog Neuropsychopharmacol Biol Psychiatry 109:110207. 2021.PMC7834650 [DOI] [PubMed]
  30. Lorant V, Deliège D, Eaton W, Robert A, Philippot P, Ansseau M.. Socioeconomic inequalities in depression: A meta-analysis. Am J Epidemiol 157(2): 98–112. 2003. doi: 10.1093/aje/kwf182. [DOI] [PubMed]
  31. Bjelland I, Krokstad S, Mykletun A, Dahl AA, Tell GS, Tambs K.. Does a higher educational level protect against anxiety and depression? The HUNT study. Soc Sci Med 66(6): 1334–45. 2008. doi: 10.1016/j.socscimed.2007.12.019. [DOI] [PubMed]
  32. Green MJ, Benzeval M.. The development of socioeconomic inequalities in anxiety and depression symptoms over the lifecourse. Soc Psychiatry Psychiatr Epidemiol 48(12):1951–61.PMC3830746 [DOI] [PubMed]
  33. Xu C, Miao L, Turner D, DeRubeis R.. Urbanicity and depression: A global meta-analysis. J Affect Disord. 2023. doi: 10.1016/j.jad.2023.08.030. [DOI] [PubMed]
  34. Ventimiglia I, Seedat S.. Current evidence on urbanicity and the impact of neighbourhoods on anxiety and stress-related disorders. Curr Opin Psychiatry 32(3):248–53. doi: 10.1097/YCO.0000000000000496. [DOI] [PubMed]
  35. Centers for Disease Control and Prevention. CDC museum COVID-19 timeline. 2023. Available from: https://www.cdc.gov/museum/timeline/covid19.html.
  36. Manchia M, Gathier AW, Yapici-Eser H, Schmidt MV, de Quervain D, van Amelsvoort T, et al. . The impact of the prolonged COVID-19 pandemic on stress resilience and mental health: A critical review across waves. Eur Neuropsychopharmacol 55:22–83. 2022.PMC8554139 [DOI] [PubMed]
  37. Hwang TJ, Rabheru K, Peisah C, Reichman W, Ikeda M.. Loneliness and social isolation during the COVID-19 pandemic. Int Psychogeriatr 32(10):1217–20. 2020.PMC7306546 [DOI] [PubMed]

RESOURCES